Literature DB >> 25139946

Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.

Gro O Nygaard1, Kristine B Walhovd2, Piotr Sowa2, Joy-Loi Chepkoech3, Atle Bjørnerud2, Paulina Due-Tønnessen4, Nils I Landrø3, Soheil Damangir5, Gabriela Spulber5, Andreas B Storsve3, Mona K Beyer2, Anders M Fjell2, Elisabeth G Celius4, Hanne F Harbo2.   

Abstract

BACKGROUND: Cortical atrophy is common in early relapsing-remitting multiple sclerosis (RRMS). Whether this atrophy is caused by changes in cortical thickness or cortical surface area is not known, nor is their separate contributions to clinical symptoms.
OBJECTIVES: To investigate the difference in cortical surface area, thickness and volume between early RRMS patients and healthy controls; and the relationship between these measures and neurological disability, cognitive decline, fatigue and depression.
METHODS: RRMS patients (n = 61) underwent magnetic resonance imaging (MRI), neurological and neuropsychological examinations. We estimated cortical surface area, thickness and volume and compared them with matched healthy controls (n = 61). We estimated the correlations between clinical symptoms and cortical measures within the patient group.
RESULTS: We found no differences in cortical surface area, but widespread differences in cortical thickness and volume between the groups. Neurological disability was related to regionally smaller cortical thickness and volume. Better verbal memory was related to regionally larger surface area; and better visuo-spatial memory, to regionally larger cortical volume. Higher depression scores and fatigue were associated with regionally smaller cortical surface area and volume.
CONCLUSIONS: We found that cortical thickness, but not cortical surface area, is affected in early RRMS. We identified specific structural correlates to the main clinical symptoms in early RRMS.
© The Author(s), 2014.

Entities:  

Keywords:  Brain function; cerebral cortex; cortical surface area; cortical thickness; depression; fatigue; magnetic resonance imaging; multiple sclerosis; neurological disability; relapsing–remitting multiple sclerosis; symptoms

Mesh:

Year:  2014        PMID: 25139946     DOI: 10.1177/1352458514543811

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  25 in total

1.  Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.

Authors:  Lior Orbach; Shay Menascu; Chen Hoffmann; Shmuel Miron; Anat Achiron
Journal:  Neuroradiology       Date:  2017-12-28       Impact factor: 2.804

2.  Regional Neocortical Gray Matter Structure and Sleep Fragmentation in Older Adults.

Authors:  Andrew S P Lim; Debra A Fleischman; Robert J Dawe; Lei Yu; Konstantinos Arfanakis; Aron S Buchman; David A Bennett
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

3.  Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis.

Authors:  Piotr Sowa; Gro Owren Nygaard; Atle Bjørnerud; Elisabeth Gulowsen Celius; Hanne Flinstad Harbo; Mona Kristiansen Beyer
Journal:  Neuroradiology       Date:  2017-06-05       Impact factor: 2.804

4.  Pregnancy leads to long-lasting changes in human brain structure.

Authors:  Elseline Hoekzema; Erika Barba-Müller; Cristina Pozzobon; Marisol Picado; Florencio Lucco; David García-García; Juan Carlos Soliva; Adolf Tobeña; Manuel Desco; Eveline A Crone; Agustín Ballesteros; Susanna Carmona; Oscar Vilarroya
Journal:  Nat Neurosci       Date:  2016-12-19       Impact factor: 24.884

5.  Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area.

Authors:  Roman Buechler; Diana Wotruba; Lars Michels; Anastasia Theodoridou; Sibylle Metzler; Susanne Walitza; Jürgen Hänggi; Spyros Kollias; Wulf Rössler; Karsten Heekeren
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

6.  Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.

Authors:  Daniel Ferreira; Lena Cavallin; Tobias Granberg; Olof Lindberg; Carlos Aguilar; Patrizia Mecocci; Bruno Vellas; Magda Tsolaki; Iwona Kłoszewska; Hilkka Soininen; Simon Lovestone; Andrew Simmons; Lars-Olof Wahlund; Eric Westman
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

7.  In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.

Authors:  Tobias Granberg; Qiuyun Fan; Constantina Andrada Treaba; Russell Ouellette; Elena Herranz; Gabriel Mangeat; Céline Louapre; Julien Cohen-Adad; Eric C Klawiter; Jacob A Sloane; Caterina Mainero
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

Review 8.  Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Authors:  Claudio Solaro; Giulia Gamberini; Fabio Giuseppe Masuccio
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

9.  Reduced cerebral cortical thickness in Non-cirrhotic patients with hepatitis C.

Authors:  Simon Hjerrild; Signe Groth Renvillard; Peter Leutscher; Leif Hougaard Sørensen; Leif Østergaard; Simon Fristed Eskildsen; Poul Videbech
Journal:  Metab Brain Dis       Date:  2015-11-03       Impact factor: 3.584

10.  A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.

Authors:  Gro O Nygaard; Elisabeth G Celius; Sigrid A de Rodez Benavent; Piotr Sowa; Marte W Gustavsen; Anders M Fjell; Nils I Landrø; Kristine B Walhovd; Hanne F Harbo
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.